Clínic Barcelona

IDIBAPS leads an 8-million-euro immunotherapy project granted by the Spanish Association Against Cancer to improve survival in hepatocellular carcinoma

Dr. Llovet (Clínic-IDIBAPS) and Dr. Bustelo (CSIC-University of Salamanca) coordinate the ASPIRE-AECC project, which includes 15 hospitals to conduct a clinical trial, as well as 10 basic-translational research centers. 

Keep reading about:

Related news